26.6
Zevra Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
millions USD
FY21:
FY22:
9.94
FY23:
24.5
FY24:
16.2
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
7.73
FY22:
−42.6
FY23:
−46.7
FY24:
−87.0
FY25:
−62.9
(positive)
Change from FY21 to FY24
millions USD
FY21:
8.25
FY22:
–
FY23:
–
FY24:
−78.4
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.52
FY22:
−26.8
FY23:
−46.0
FY24:
−90.1
FY25:
86.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.56
FY22:
−26.8
FY23:
−46.0
FY24:
−106
FY25:
83.2
All amounts in millions USD